257 related articles for article (PubMed ID: 27799305)
1. Heat Shock Protein 90 Facilitates Latent HIV Reactivation through Maintaining the Function of Positive Transcriptional Elongation Factor b (p-TEFb) under Proteasome Inhibition.
Pan XY; Zhao W; Wang CY; Lin J; Zeng XY; Ren RX; Wang K; Xun TR; Shai Y; Liu SW
J Biol Chem; 2016 Dec; 291(50):26177-26187. PubMed ID: 27799305
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.
Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J
J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242
[TBL] [Abstract][Full Text] [Related]
3. Thiostrepton Reactivates Latent HIV-1 through the p-TEFb and NF-κB Pathways Mediated by Heat Shock Response.
Peng W; Hong Z; Chen X; Gao H; Dai Z; Zhao J; Liu W; Li D; Deng K
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094131
[TBL] [Abstract][Full Text] [Related]
4. Short Communication: The Broad-Spectrum Histone Deacetylase Inhibitors Vorinostat and Panobinostat Activate Latent HIV in CD4(+) T Cells In Part Through Phosphorylation of the T-Loop of the CDK9 Subunit of P-TEFb.
Jamaluddin MS; Hu PW; Jan Y; Siwak EB; Rice AP
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):169-73. PubMed ID: 26727990
[TBL] [Abstract][Full Text] [Related]
5. Quiescence Promotes Latent HIV Infection and Resistance to Reactivation from Latency with Histone Deacetylase Inhibitors.
Painter MM; Zaikos TD; Collins KL
J Virol; 2017 Dec; 91(24):. PubMed ID: 29021396
[TBL] [Abstract][Full Text] [Related]
6. HSF1 inhibition attenuates HIV-1 latency reversal mediated by several candidate LRAs In Vitro and Ex Vivo.
Timmons A; Fray E; Kumar M; Wu F; Dai W; Bullen CK; Kim P; Hetzel C; Yang C; Beg S; Lai J; Pomerantz JL; Yukl SA; Siliciano JD; Siliciano RF
Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15763-15771. PubMed ID: 32571938
[TBL] [Abstract][Full Text] [Related]
7. Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency.
Li Z; Wu J; Chavez L; Hoh R; Deeks SG; Pillai SK; Zhou Q
PLoS Pathog; 2019 Jan; 15(1):e1007498. PubMed ID: 30645648
[TBL] [Abstract][Full Text] [Related]
8. PR-957, a selective immunoproteasome inhibitor, reactivates latent HIV-1 through p-TEFb activation mediated by HSF-1.
Lin J; Zhang X; Lu W; Xu X; Pan X; Liang T; Duan S; Chen Y; Li L; Liu S
Biochem Pharmacol; 2018 Oct; 156():511-523. PubMed ID: 30170098
[TBL] [Abstract][Full Text] [Related]
9. PARP1 Might Substitute HSF1 to Reactivate Latent HIV-1 by Binding to Heat Shock Element.
Xu X; Lin Y; Zeng X; Yang C; Duan S; Ding L; Lu W; Lin J; Pan X; Ma X; Liu S
Cells; 2022 Jul; 11(15):. PubMed ID: 35954175
[TBL] [Abstract][Full Text] [Related]
10. A novel bromodomain inhibitor, CPI-203, serves as an HIV-1 latency-reversing agent by activating positive transcription elongation factor b.
Liang T; Zhang X; Lai F; Lin J; Zhou C; Xu X; Tan X; Liu S; Li L
Biochem Pharmacol; 2019 Jun; 164():237-251. PubMed ID: 30991051
[TBL] [Abstract][Full Text] [Related]
11. Heat Shock Factor 1 Mediates Latent HIV Reactivation.
Pan XY; Zhao W; Zeng XY; Lin J; Li MM; Shen XT; Liu SW
Sci Rep; 2016 May; 6():26294. PubMed ID: 27189267
[TBL] [Abstract][Full Text] [Related]
12. Short communication: SAHA (vorinostat) induces CDK9 Thr-186 (T-loop) phosphorylation in resting CD4+ T cells: implications for reactivation of latent HIV.
Ramakrishnan R; Liu H; Rice AP
AIDS Res Hum Retroviruses; 2015 Jan; 31(1):137-41. PubMed ID: 24528253
[TBL] [Abstract][Full Text] [Related]
13. An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression.
Darcis G; Kula A; Bouchat S; Fujinaga K; Corazza F; Ait-Ammar A; Delacourt N; Melard A; Kabeya K; Vanhulle C; Van Driessche B; Gatot JS; Cherrier T; Pianowski LF; Gama L; Schwartz C; Vila J; Burny A; Clumeck N; Moutschen M; De Wit S; Peterlin BM; Rouzioux C; Rohr O; Van Lint C
PLoS Pathog; 2015 Jul; 11(7):e1005063. PubMed ID: 26225566
[TBL] [Abstract][Full Text] [Related]
14. TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb.
Ma X; Yang T; Luo Y; Wu L; Jiang Y; Song Z; Pan T; Liu B; Liu G; Liu J; Yu F; He Z; Zhang W; Yang J; Liang L; Guan Y; Zhang X; Li L; Cai W; Tang X; Gao S; Deng K; Zhang H
Elife; 2019 Jan; 8():. PubMed ID: 30652970
[TBL] [Abstract][Full Text] [Related]
15. Biogenesis of P-TEFb in CD4+ T cells to reverse HIV latency is mediated by protein kinase C (PKC)-independent signaling pathways.
Mbonye U; Leskov K; Shukla M; Valadkhan S; Karn J
PLoS Pathog; 2021 Sep; 17(9):e1009581. PubMed ID: 34529720
[TBL] [Abstract][Full Text] [Related]
16. A chalcone derivative reactivates latent HIV-1 transcription through activating P-TEFb and promoting Tat-SEC interaction on viral promoter.
Wu J; Ao MT; Shao R; Wang HR; Yu D; Fang MJ; Gao X; Wu Z; Zhou Q; Xue YH
Sci Rep; 2017 Sep; 7(1):10657. PubMed ID: 28878233
[TBL] [Abstract][Full Text] [Related]
17. BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency.
Lu P; Shen Y; Yang H; Wang Y; Jiang Z; Yang X; Zhong Y; Pan H; Xu J; Lu H; Zhu H
Sci Rep; 2017 Nov; 7(1):16646. PubMed ID: 29192216
[TBL] [Abstract][Full Text] [Related]
18. Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus.
Acchioni C; Remoli AL; Marsili G; Acchioni M; Nardolillo I; Orsatti R; Farcomeni S; Palermo E; Perrotti E; Barreca ML; Sabatini S; Sandini S; Parolin C; Lin R; Borsetti A; Hiscott J; Sgarbanti M
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243131
[TBL] [Abstract][Full Text] [Related]
19. Heat shock protein 90 controls HIV-1 reactivation from latency.
Anderson I; Low JS; Weston S; Weinberger M; Zhyvoloup A; Labokha AA; Corazza G; Kitson RA; Moody CJ; Marcello A; Fassati A
Proc Natl Acad Sci U S A; 2014 Apr; 111(15):E1528-37. PubMed ID: 24706778
[TBL] [Abstract][Full Text] [Related]
20. The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure Strategies.
Rice AP
Curr Pharm Des; 2017; 23(28):4098-4102. PubMed ID: 28677507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
